Yargesa Capsule
Product Images NDC 42799-709

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Yargesa (NDC 42799-709). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Edenbridge Pharmaceuticals Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Miglustat Structure)

Chemical structure of miglustat, the active ingredient in Yargesa 100 mg capsules. The diagram shows a six-membered ring with nitrogen and multiple hydroxyl groups, along with methyl substituents, illustrating the molecular arrangement of this oral human prescription drug.*

FDA Label Image

Box (Yargesa 15 Ct)

Yargesa 100 mg capsules packaging label showing the brand name and strength prominently in green and white. The label states it contains miglustat capsules for oral use, with 15 unit-dose capsules per package. Manufactured by Edenbridge Pharmaceuticals LLC, Parsippany, NJ. Includes inactive ingredients and storage instructions, with a barcode and NDC 42799-709-15.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.